[HTML][HTML] Nanovaccines: a game changing approach in the fight against infectious diseases
The field of nanotechnology has revolutionised global attempts to prevent, treat, and
eradicate infectious diseases in the foreseen future. Nanovaccines have proven to be a …
eradicate infectious diseases in the foreseen future. Nanovaccines have proven to be a …
Replicating viral vector-based vaccines for COVID-19: potential avenue in vaccination arena
The “severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” is the third member of
human coronavirus (CoV) that is held accountable for the current “coronavirus disease 2019 …
human coronavirus (CoV) that is held accountable for the current “coronavirus disease 2019 …
SARS-CoV-2 vaccines, vaccine development technologies, and significant efforts in vaccine development during the pandemic: the lessons learned might help to fight …
We are currently approaching three years since the beginning of the coronavirus disease
2019 (COVID-19) pandemic. SARS-CoV-2 has caused extensive disruptions in everyday …
2019 (COVID-19) pandemic. SARS-CoV-2 has caused extensive disruptions in everyday …
COVID-19 booster vaccination hesitancy in the United States: a multi-theory-model (MTM)-based national assessment
Background: Despite the availability of COVID-19 vaccines and the proven benefits of
vaccinations outweighing the potential risks, hesitancy to accept vaccines and additional …
vaccinations outweighing the potential risks, hesitancy to accept vaccines and additional …
Chitosan-based nanomaterial as immune adjuvant and delivery carrier for vaccines
With the support of modern biotechnology, vaccine technology continues to iterate. The
safety and efficacy of vaccines are some of the most important areas of development in the …
safety and efficacy of vaccines are some of the most important areas of development in the …
Perception of COVID-19 booster dose vaccine among healthcare workers in India and Saudi Arabia
S Vellappally, S Naik, O Alsadon, AA Al-Kheraif… - International journal of …, 2022 - mdpi.com
Background: COVID-19 vaccines were made available to the public by the end of 2020.
However, little is known about COVID-19 booster dose (CBD) vaccine perception among …
However, little is known about COVID-19 booster dose (CBD) vaccine perception among …
[HTML][HTML] Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
yet to be controlled worldwide, especially in India. The second wave of coronavirus disease …
yet to be controlled worldwide, especially in India. The second wave of coronavirus disease …
COVID‐19 vaccinations and rates of infections, hospitalizations, ICU admissions, and deaths in Europe during SARS‐CoV‐2 Omicron wave in the first quarter of 2022
The vaccination campaigns brought hope to minimizing the coronavirus disease 2019
(COVID‐19) burden. However, the emergence of novel, highly transmissible Omicron …
(COVID‐19) burden. However, the emergence of novel, highly transmissible Omicron …
Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients
J Bruminhent, C Setthaudom, R Kitpermkiat… - Scientific reports, 2022 - nature.com
Vaccination with inactivated SARS-CoV-2 virus produces suboptimal immune responses
among kidney transplant (KT), peritoneal dialyzed (PD), and hemodialyzed (HD) patients …
among kidney transplant (KT), peritoneal dialyzed (PD), and hemodialyzed (HD) patients …
Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis
S Xu, J Li, H Wang, F Wang, Z Yin, Z Wang - BMC medicine, 2023 - Springer
Background The two inactivated SARS-CoV-2 vaccines, CoronaVac and BBIBP-CorV, have
been widely used to control the COVID-19 pandemic. The influence of multiple factors on …
been widely used to control the COVID-19 pandemic. The influence of multiple factors on …